Quick answer
Cencora, Inc. (COR) reported revenue of $321.33B and net income of $1.55B for the fiscal year ended 2025-09-30, up 9.3% from $293.96B the year before, per its 10-K filed with the SEC on 2025-11-25. Long-term debt stood at $7.66B.
Data as of 2025-09-30. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-09-30) | $321.33B | $1.55B | $7.66B |
| 2024 (FY ending 2024-09-30) | $293.96B | $1.51B | $4.39B |
| 2023 (FY ending 2023-09-30) | $262.17B | $1.75B | $4.79B |
| 2022 (FY ending 2022-09-30) | $238.59B | $1.70B | $5.70B |
| 2021 (FY ending 2021-09-30) | $213.99B | $1.54B | $6.68B |
| 2020 (FY ending 2020-09-30) | $189.89B | -$3.41B | $4.12B |
| 2019 (FY ending 2019-09-30) | $179.59B | $855.4M | $4.03B |
| 2018 (FY ending 2018-09-30) | $167.94B | $1.66B | $4.16B |
| 2017 (FY ending 2017-09-30) | $153.14B | $364.5M | $3.44B |
| 2016 (FY ending 2016-09-30) | $146.85B | $1.43B | $4.19B |
Related
- COLB revenue, net income and debt history (Columbia Banking System, Inc.)
- COO revenue, net income and debt history (The Cooper Companies, Inc.)
- COP revenue, net income and debt history (ConocoPhillips)
- CORT revenue, net income and debt history (Corcept Therapeutics Inc)
- COST revenue, net income and debt history (Costco Wholesale Corp /New)
- CPAY revenue, net income and debt history (Corpay, Inc)
- CPNG revenue, net income and debt history (Coupang, Inc.)
- CPRT revenue, net income and debt history (Copart, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.